BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7790123)

  • 1. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
    Sung MW; Yasumura S; Johnson JT; Van Dongen GA; Whiteside TL
    Int J Cancer; 1995 Jun; 61(6):864-72. PubMed ID: 7790123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-(epidermal growth factor) receptor monoclonal antibodies for the induction of antibody-dependent cell-mediated cytotoxicity against squamous cell carcinoma lines of the head and neck.
    Bier H; Hoffmann T; Haas I; van Lierop A
    Cancer Immunol Immunother; 1998 May; 46(3):167-73. PubMed ID: 9625540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck.
    Taylor RJ; Chan SL; Wood A; Voskens CJ; Wolf JS; Lin W; Chapoval A; Schulze DH; Tian G; Strome SE
    Cancer Immunol Immunother; 2009 Jul; 58(7):997-1006. PubMed ID: 18979096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.
    van Gog FB; Brakenhoff RH; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1997 Apr; 44(2):103-11. PubMed ID: 9177472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity.
    Liu Z; Smyth FE; Renner C; Lee FT; Oosterwijk E; Scott AM
    Cancer Immunol Immunother; 2002 May; 51(3):171-7. PubMed ID: 11941456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.
    Mata MM; Mahmood F; Sowell RT; Baum LL
    J Immunol Methods; 2014 Apr; 406():1-9. PubMed ID: 24561308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.
    Taylor RJ; Saloura V; Jain A; Goloubeva O; Wong S; Kronsberg S; Nagilla M; Silpino L; de Souza J; Seiwert T; Vokes E; Villaflor V; Cohen EE
    Cancer Immunol Res; 2015 May; 3(5):567-74. PubMed ID: 25769300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancer.
    Brakenhoff RH; van Gog FB; Looney JE; van Walsum M; Snow GB; van Dongen GA
    Cancer Immunol Immunother; 1995 Mar; 40(3):191-200. PubMed ID: 7728778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
    Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting.
    Snyder KM; Dixon KJ; Davis Z; Hosking M; Hart G; Khaw M; Matson A; Bjordahl R; Hancock B; Shirinbak S; Miller JS; Valamehr B; Wu J; Walcheck B
    J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.
    Primus FJ; Pendurthi TK; Hutzell P; Kashmiri S; Slavin DC; Callahan R; Schlom J
    Cancer Immunol Immunother; 1990; 31(6):349-57. PubMed ID: 2386980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells.
    Abdullah N; Greenman J; Pimenidou A; Topping KP; Monson JR
    Cancer Immunol Immunother; 1999 Dec; 48(9):517-24. PubMed ID: 10602889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.
    Gubbels JA; Gadbaw B; Buhtoiarov IN; Horibata S; Kapur AK; Patel D; Hank JA; Gillies SD; Sondel PM; Patankar MS; Connor J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1789-800. PubMed ID: 21792658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of apoptosis in antibody-dependent cellular cytotoxicity.
    Curnow SJ; Glennie MJ; Stevenson GT
    Cancer Immunol Immunother; 1993; 36(3):149-55. PubMed ID: 8439975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v6 specific CAR-NK cells for targeted immunotherapy of head and neck squamous cell carcinoma.
    Ciulean IS; Fischer J; Quaiser A; Bach C; Abken H; Tretbar US; Fricke S; Koehl U; Schmiedel D; Grunwald T
    Front Immunol; 2023; 14():1290488. PubMed ID: 38022580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Abe S; Kakiuchi S; Kishuku M; Minakuchi K; Matsumoto T; Sone S
    Cancer Immunol Immunother; 2009 Jun; 58(6):967-76. PubMed ID: 18979097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation of hematopoietic cell lines induced by a soluble factor derived from human squamous cell carcinomas of the head and neck.
    Yasumura S; Amoscato A; Hirabayashi H; Lin WC; Whiteside TL
    Cancer Immunol Immunother; 1994 Dec; 39(6):407-15. PubMed ID: 8001029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor Cells.
    Felices M; Lenvik TR; Davis ZB; Miller JS; Vallera DA
    Methods Mol Biol; 2016; 1441():333-46. PubMed ID: 27177679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck.
    Hoffmann TK; Bier H; Whiteside TL
    Cancer Immunol Immunother; 2004 Dec; 53(12):1055-67. PubMed ID: 15095020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer.
    Schantz SP; Brown BW; Lira E; Taylor DL; Beddingfield N
    Cancer Immunol Immunother; 1987; 25(2):141-8. PubMed ID: 3499224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.